BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19833056)

  • 1. Interleukin-21 in T cell-mediated diseases.
    Monteleone G; Sarra M; Pallone F
    Discov Med; 2009 Oct; 8(42):113-7. PubMed ID: 19833056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease.
    Monteleone G; Pallone F; Macdonald TT
    Cytokine Growth Factor Rev; 2009 Apr; 20(2):185-91. PubMed ID: 19261537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32).
    Conti P; Youinou P; Theoharides TC
    Autoimmun Rev; 2007 Jan; 6(3):131-7. PubMed ID: 17289547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
    Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
    Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells.
    Caruso R; Fina D; Peluso I; Stolfi C; Fantini MC; Gioia V; Caprioli F; Del Vecchio Blanco G; Paoluzi OA; Macdonald TT; Pallone F; Monteleone G
    Gastroenterology; 2007 Jan; 132(1):166-75. PubMed ID: 17241869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-21 as a new therapeutic target for immune-mediated diseases.
    Monteleone G; Pallone F; Macdonald TT
    Trends Pharmacol Sci; 2009 Aug; 30(8):441-7. PubMed ID: 19616319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-28A is a key regulator of T-cell-mediated liver injury via the T-box transcription factor T-bet.
    Siebler J; Wirtz S; Weigmann B; Atreya I; Schmitt E; Kreft A; Galle PR; Neurath MF
    Gastroenterology; 2007 Jan; 132(1):358-71. PubMed ID: 17241885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of gut inflammation and th17 cell response by interleukin-21.
    Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
    Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune modulation with interleukin-21.
    Bhave NS; Carson WE
    Ann N Y Acad Sci; 2009 Dec; 1182():39-46. PubMed ID: 20074273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine growth of CD4+ T cells. Differential effects of IL-1 on helper and inflammatory T cells.
    Greenbaum LA; Horowitz JB; Woods A; Pasqualini T; Reich EP; Bottomly K
    J Immunol; 1988 Mar; 140(5):1555-60. PubMed ID: 2964479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses.
    Habib T; Nelson A; Kaushansky K
    J Allergy Clin Immunol; 2003 Dec; 112(6):1033-45. PubMed ID: 14657853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-21 signaling: functions in cancer and autoimmunity.
    Davis ID; Skak K; Smyth MJ; Kristjansen PE; Miller DM; Sivakumar PV
    Clin Cancer Res; 2007 Dec; 13(23):6926-32. PubMed ID: 18056166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice.
    Jang E; Cho SH; Park H; Paik DJ; Kim JM; Youn J
    J Immunol; 2009 Apr; 182(8):4649-56. PubMed ID: 19342640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-22 and inflammation: leukin' through a glass onion.
    Zenewicz LA; Flavell RA
    Eur J Immunol; 2008 Dec; 38(12):3265-8. PubMed ID: 19016525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling through the murine T cell receptor induces IL-17 production in the absence of costimulation, IL-23 or dendritic cells.
    Liu XK; Clements JL; Gaffen SL
    Mol Cells; 2005 Dec; 20(3):339-47. PubMed ID: 16404147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-21-induced Bepsilon cell apoptosis mediated by natural killer T cells suppresses IgE responses.
    Harada M; Magara-Koyanagi K; Watarai H; Nagata Y; Ishii Y; Kojo S; Horiguchi S; Okamoto Y; Nakayama T; Suzuki N; Yeh WC; Akira S; Kitamura H; Ohara O; Seino K; Taniguchi M
    J Exp Med; 2006 Dec; 203(13):2929-37. PubMed ID: 17178921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-23 and T(H)17-mediated inflammation in human allergic contact dermatitis.
    Larsen JM; Bonefeld CM; Poulsen SS; Geisler C; Skov L
    J Allergy Clin Immunol; 2009 Feb; 123(2):486-92. PubMed ID: 18986691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells.
    Fantini MC; Rizzo A; Fina D; Caruso R; Becker C; Neurath MF; Macdonald TT; Pallone F; Monteleone G
    Eur J Immunol; 2007 Nov; 37(11):3155-63. PubMed ID: 17918200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis.
    Zheng Y; Danilenko DM; Valdez P; Kasman I; Eastham-Anderson J; Wu J; Ouyang W
    Nature; 2007 Feb; 445(7128):648-51. PubMed ID: 17187052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
    Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
    Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.